Persistent pancytopenia following gynecologic cancer treatment warrants evaluation for t-MDS, a secondary malignancy associated with poor outcomes.

Gynecologic cancer highlights from ESMO 2026 include results from FONTANA, REJOICE-Ovarian02, and other studies with positive ...

Merieme Klobocista, MD, of Hackensack Meridian Health explains how molecular testing is personalizing treatment for ovarian ...

Community education should emphasize which gynecologic cancers have screening, which do not, and which symptoms merit prompt evaluation by appropriate clinicians. Molecular testing of tumor ...

A planned randomized trial of 200 patients treated for gynecologic cancer will compare a communication intervention with ...

For decades, gynecologic cancer treatment has used aggressive surgical intervention and chemotherapy. These methods often harmed fertility. They also caused severe side effects and an uncertain ...

Jayson Field, is the director of the Division of Gynecologic Oncology within the Michigan State University College of Human Medicine and provides care as a gynecologic oncologist at MSU Health Care.

Surgery for gynecologic cancers is a common form of treatment, but each surgical approach has its advantages and disadvantages for patients. For patients with gynecologic cancers, opting for minimally ...

"If you feel like you need to pee but you can’t, you need to go to the doctor..." ...

Merieme Klobocista, MD, explains how surgical history, disease burden, and body habits guide minimally invasive surgery decisions in gynecologic cancer.

Newswise — Gynecologic cancers, including cervical, ovarian, uterine/endometrial, vaginal, and vulvar cancers, affect thousands worldwide each year. Despite the prevalence of these cancers, awareness ...

Women with gynecologic cancers who meet criteria for malnutrition before surgery face a higher risk for poor postoperative outcomes. However, the value of preoperative malnutrition assessments depends ...